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The Double-Stranded RNA Analogue
Polyinosinic-Polycytidylic Acid Induces
Keratinocyte Pyroptosis and Release of IL-36c
Li-Hua Lian1,2, Katelynn A. Milora1,2, Katherine K. Manupipatpong1 and Liselotte E. Jensen1
IL-36 is the common name for the three IL-1 family members IL-36a, IL-36b, and IL-36g, formerly known as IL-1F6,
IL-1F8, and IL-1F9, respectively. IL-36 appears to have pro-inflammatory activities; however, the physiological
function of these cytokines remains unknown. Expression of IL-36 by keratinocytes implies its possible
involvement in innate immune responses in the skin. We observed that, of the three IL-36 isoforms, human
keratinocytes express high levels of IL-36g. IL-36g mRNA expression was dramatically induced by the Toll-like
receptor ligands polyinosinic-polycytidylic acid (poly(I:C)) and flagellin. Surprisingly, the IL-36g protein was
released by cells treated with poly(I:C), but remained intracellular in cells treated with flagellin only. poly(I:C),
but not flagellin, induced cell death and caspase-3/7 activation. Inhibition of caspase-3/7 and caspase-1 blocked
extracellular release of IL-36g from poly(I:C)-treated cells. Furthermore, caspase-1 inhibition prevented
poly(I:C)-induced caspase-3/7 activation. Interestingly, transcription of the gene IL36G was dependent on
caspase-1, but not caspase-3/7, activation. This demonstrates that the pathways leading to IL36G transcription
and caspase-3/7 activation branch after caspase-1. This divergence of the pathways allows the cells to enter a
state of de novo protein synthesis before committing to pyroptosis. Overall, our observations suggest that IL-
36g may be an alarmin that signals the cause, e.g., viral infection, of cell death.
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INTRODUCTION
The skin is continuously exposed to potential pathogens and
plays an active role in initiating immune responses to
eliminate these microorganisms. Keratinocytes express func-
tionally active pathogen-associated molecular pattern recog-
nition receptors such as the Toll-like receptors (TLRs) and
retinoic acid–inducible gene-I–like receptors (Kalali et al.
(2008) and references therein). Different TLRs bind a diverse
range of structural motifs associated with bacteria, fungi, and
viruses. In contrast, retinoic acid–inducible gene-I–like
receptors appear to be specific for viral double-stranded
RNA (Takeuchi and Akira, 2010). Engagement of TLRs and
retinoic acid–inducible gene-I–like receptors activates intra-
cellular signaling pathways, which regulate the expression of
pro-inflammatory cytokines (Takeuchi and Akira, 2010).
Release of these cytokines from keratinocytes subsequently
orchestrates the recruitment and activation of immune cells.
IL-1 and IL-18 are among the many pro-inflammatory
cytokines that are expressed following TLR and/or retinoic
acid–inducible gene-I–like receptor engagement. IL-18 is
considered to be an IL-1 family member due to sequence
and structural similarity to IL-1. There are two forms of IL-1:
IL-1a is the foremost form produced by keratinocytes, whereas
IL-1b is primarily expressed by myeloid cells (Dinarello, 2009).
With the recent discovery of the inflammasomes, which are
intracellular protein complexes involved in the initiation of
inflammation (van de Veerdonk et al., 2011), the process
whereby myeloid cells secrete IL-1b and IL-18 has gained
renewed interest. Both cytokines lack signal peptides and are
initially produced as pro-proteins. Assembly of the inflamma-
somes activates the protease caspase-1, which in turn cleaves
the pro-IL-1b and pro-IL-18 (van de Veerdonk et al., 2011). This
process permits extracellular release of the mature cytokines
through a process called pyroptosis (Franchi et al., 2009).
Pyroptosis is a highly inflammatory form of programmed cell
death. The process is dependent on caspase-1 activation and
has so far only been described in myeloid cells (Franchi et al.,
2009). Although it is known that keratinocytes have inflamma-
somes (Feldmeyer et al., 2010), how IL-1 cytokines are released
from keratinocytes is poorly understood.
IL-36a (formerly known as IL-1F6), IL-36b (IL-1F8), and
IL-36g (IL-1F9) are three recently discovered new members of
the IL-1 family (Dinarello et al., 2010). IL-36 binds to IL-1
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receptor–like 2 (IL-1RL2) to initiate intracellular activation of
mitogen-activated protein kinase and NF-kB signal transduction
(Debets et al., 2001; Towne et al., 2004). IL-1RL2 is primarily
expressed in epithelial cells of tissues, such as the skin, lungs,
and digestive tract. Recent studies have demonstrated that
transgenic overexpression of IL-36a in basal keratinocytes leads
to a psoriasis-like phenotype (Blumberg et al., 2007), and
intratracheal administration of recombinant IL-36g in mice
results in increased neutrophil influx (Ramadas et al., 2011).
These studies suggest that IL-36 has pro-inflammatory activities.
Epidermal expression of the IL-36 and IL-1RL2 mRNAs is
upregulated in many inflammatory skin conditions, such as
psoriasis and eczema (reviewed in Jensen, 2010). However, the
specific physiological functions of the three IL-36 isoforms and
how they may contribute to disease remain unclear.
The high degree of IL-36 and IL-1RL2 expression in tissues
in direct contact with the environment may suggest that these
proteins are involved in first-line defenses against micro-
organisms colonizing these areas. To initiate studies of this
hypothesis, we explored the expression of IL-36 cytokines in
keratinocytes. Our investigations presented here establish
that keratinocytes respond differently depending on how they
are challenged. Furthermore, we demonstrate that the
double-stranded RNA analogue poly(I:C) induces pyroptosis
in keratinocytes, thereby facilitating the extracellular release
of IL-36g. To our knowledge this is previously unreported.
RESULTS
TLR ligands induce dramatic changes in IL-36c expression
Since IL-36 is expressed in the skin (Jensen, 2010), we
speculated that these cytokines play a role in the homeostatic
processes regulating the continuous interaction between the
skin and colonizing or invading microorganisms. We first
compared expression of the new IL-36 cytokines to the
classical IL-1 family members IL-1a and IL-1b in unstimulated
cells. Levels of the IL-36a mRNA were the lowest observed.
Relative to the IL-36a mRNA, levels of IL-36b, IL-36g, IL-1b,
and IL-1a mRNAs were 3,100-, 25,000-, 190,000-, and
1,800,000 times higher, respectively (Figure 1a). No discern-
able differences were noticed between adult and neonatal
keratinocytes (data not shown).
Keratinocytes were challenged with a panel of TLR ligands
to examine their capacity to stimulate IL-1 and IL-36 mRNA
expression (Figure 1b). While the IL-1a and IL-1b mRNA
levels were modestly increased (1.5- to 4-fold, Po0.05) by
most TLR ligands, the IL-36b and IL-36g mRNAs were most
significantly (Po0.05) regulated by flagellin (4- and 24-fold,
respectively) and poly(I:C) (8- and 143-fold, respectively).
The dramatic induction of the IL-36g mRNA by poly(I:C) was
concentration dependent (Figure 1c) and resulted in mRNA
levels similar to that of the IL-1a mRNA (compare Figure 1a
and b). The very clear differential expression patterns of IL-1
versus IL-36 suggest that these proteins have distinct functions.
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Figure 1. Expression of IL-1 and IL-36 in human primary keratinocytes. Keratinocytes were left (a) untreated or (b) treated with medium only, polyinosinic-
polycytidylic acid (poly(I:C)) (25 mgml1), flagellin (1 mgml1), Escherichia coli DNA (10 mgml1), lipoteichoic acid (LTA) (5 mgml1), lipopolysaccharide
(LPS) (5mgml1), or zymosan (25mgml1), or (c) treated with medium only or poly(I:C) at the indicated concentrations. Total RNA was isolated
after 1, 6, or 24 hours and reverse transcription and real-time PCR performed. IL-1 family mRNA levels were normalized against glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) and fold differences (mean±standard deviation (SD), n¼ 2 per independent timepoint and treatment) calculated relative to the (a)
IL-36a mRNA or (b and c) medium-only treated samples. Only IL-36g mRNA expression was examined in c. *Po0.05; **Po0.01; ***Po0.001
(comparing treatment with medium only at the (b and c) same timepoint or (a and c) as indicated). Data shown are from one representative experiment of
at least three independent experiments.
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Similar to previous reports (Kumar et al., 2000; Debets
et al., 2001), we also observed increased IL-36b and IL-36g
mRNA expression in response to IL-1 and TNFa (data not
shown). As observed with the TLR ligands (Figure 1b), IL-36g
was the most noticeably regulated (approx. 25-fold increases
vs. maximum 12-fold increases in IL-36b mRNA levels (data
not shown)). Other cytokines such as IFN-g and IL-6 did not
affect the degree of IL-36 mRNA expression (data not shown).
Several additional cytokines have been shown to regulate IL-
36 expression, including IL-17A, IL-22, and IL-36 itself
(Carrier et al., 2011; Muhr et al., 2011). Although we
observed no indication of a biphasic expression profile in the
dose–response curves or time courses (Figure 1b and c), it is
plausible that the dramatic induction of the IL-36g mRNA is,
in part, driven by an autocrine mechanism involving IL-36
(see below with regard to extracellular localization of IL-36).
IL-36c is only secreted in response to poly(I:C)
Similar to IL-1b, the IL-36 cytokines lack signal peptides
required for conventional protein secretion ((Martin et al.
(2009) and references therein). Interestingly, unlike IL-1b,
which is synthesized as a pro-protein that is cleaved before
extracellular release, the IL-36 proteins appear to lack pro-
domains. Hence, they are predicted to be transcribed directly
into mature cytokine forms (Martin et al., 2009). We therefore
examined whether IL-36b and IL-36g were present in the
medium or cellular fractions of cells treated with TLR ligands.
Since both poly(I:C) and flagellin significantly increased IL-
36b and IL-36g mRNA levels (Figure 1b), we predicted that
these TLR ligands would trigger a corresponding rise in IL-
36b and IL-36g production. Furthermore, cellular localization
was anticipated to be similar. Surprisingly, we found that IL-
36g could only be detected in the medium from cells
stimulated with poly(I:C) (Figure 2a). The level of IL-36g
secretion was dependent on the poly(I:C) concentration
(Figure 2b). We were unable to detect IL-36b in the same
samples (data not shown). In contrast, flagellin-activated cells
contained increased levels of intracellular IL-36g (Figure 2c).
A low level of intracellular IL-36g could also be detected in
poly(I:C)-treated cell fractions. No discernable size differ-
ences between the intracellular and extracellular IL-36g were
detected.
It is well known that ATP stimulates the release of
intracellular IL-1b by macrophages (Franchi et al., 2009).
Overexpression of a murine green fluorescence protein–IL-
36a fusion protein in mouse macrophages results in
intracellular protein buildup. This cytokine fusion protein is
secreted when cells are treated with ATP (Martin et al., 2009).
Similar to this, we found that a 20-minute pulse with 5mM
ATP stimulated the extracellular release of IL-36g (data not
shown), which accumulated in cells treated with flagellin.
Similar observations have recently been reported by Johnston
et al. (2011).
poly(I:C) causes cell death and caspase-3/7 activation
During our analyses of IL-36 expression in response to TLR
ligands, we observed lower cell density 24 hours after
poly(I:C) treatments compared with other agent applications
(Figure 3a). Staining with Trypan blue indicated that 40–60%
of the cells remained alive 24 hours after poly(I:C) addition
(data not shown). The poly(I:C)-treated cultures further
revealed cell morphologies suggestive of cells at different
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Figure 2. Extracellular and intracellular localization of IL-36c from Toll-like
receptor (TLR) ligand–activated keratinocytes. Cells were treated as
described in Figure 1b and c. The medium and cells were collected at the
indicated timepoints and (a and b) extracellular (medium) and (c) intracellular
(cells) IL-36g levels examined by (a and c) western blotting or (b) ELISA.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading
control for intracellular protein fractions. *Po0.05; **Po0.01 (comparing
treatment with medium only at the same timepoint or as indicated). LPS,
lipopolysaccharide; LTA, lipoteichoic acid; poly(I:C), polyinosinic-
polycytidylic acid.
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stages of cell death (Figure 3a, arrowheads). Activation of
caspase-3 and -7 commits cells to undergo programmed cell
death such as apoptosis (Lakhani et al., 2006). We therefore
speculated that pro-apoptotic caspase activity would be
present at earlier timepoints. Preliminary microscopic
observations of cultures revealed that around 6 hours post-
treatment, a few single dispersed cells, which appeared to be
dying, could be observed only in cultures treated with
poly(I:C) (data not shown). Measurements of intracellular ATP
levels revealed significant reduction in the number of viable
cells when cultures were treated with poly(I:C) compared
with those treated with medium only or flagellin (Figure 3b).
Further measurements of active caspase-3/7 demonstrated a
significant 8-fold (Po0.05) increase in caspase activity
compared with cells treated with medium only (Figure 3c).
In comparison, caspase-3/7 was not significantly activated in
cells treated with flagellin (Figure 3c).
poly(I:C)-induced IL-36c extracellular release is caspase-3
dependent
Since poly(I:C), but not flagellin, caused cell death, caspase-3/7
activation, and extracellular release of IL-36g, we speculated
that the poly(I:C)-induced release of IL-36g was dependent
on the caspase-3/7-mediated cell death. Inclusion of
the target-specific caspase-3/7 inhibitor III significantly
(Po0.01) blocked the extracellular release of IL-36g
(Figure 4a). Furthermore, in the presence of the caspase-3/7
inhibitor, the de novo synthesized IL-36g instead accumu-
lated inside the cells (Figure 4b). The caspase-3/7 inhibitor
had no effect on the poly(I:C)-induced IL-36g mRNA
expression (Figure 4c).
Caspase-1 is an upstream activator of caspase-3/7
In myeloid cells, the pyroptosis-associated release of IL-1b
and IL-18 requires activation of caspase-1 (Franchi et al.,
2009). Furthermore, caspase-1 can activate caspase-7 (Lam-
kanfi et al., 2008). To examine whether caspase-1 is an
upstream activator of caspase-3/7 in keratinocytes, we treated
cells with poly(I:C) in the presence and absence of the
caspase-1 inhibitor VI and then examined caspase-3/7
activity. Inclusion of the caspase-1 inhibitor prevented
caspase-3/7 activation (Figure 5a; Po0.05), demonstrating
that poly(I:C)-mediated caspase-3/7 activation requires prior
caspase-1 activation.
IL-36c expression is caspase-1 dependent
In analogy with the above studies on the role of caspase-3/7
in the release of IL-36g, we next examined whether IL-36g
secretion was caspase-1 dependent. Inclusion of the target-
specific caspase-1 inhibitor blocked (Po0.05) extracellular
accumulation of IL-36g (Figure 5b) in a manner similar to that
observed when caspase-3/7 activation was prevented (Figure
4a). However, while caspase-3/7 inhibition resulted in
intracellular IL-36g accumulation (Figure 4b), IL-36g did not
build up in the cells when caspase-1 was specifically
inhibited (Figure 5c). We therefore examined IL-36g mRNA
expression in the presence and absence of the caspase-1
inhibitor. Interestingly, we found that the poly(I:C)-mediated
increase in IL-36gmRNA expression was prevented (Po0.01)
by blocking caspase-1 activity (Figure 5d). This demonstrates
that the poly(I:C)-induced IL-36g gene expression is caspase-
1 dependent (Figure 6). Since expression of the IL-36g-
encoding gene (IL36G) is not caspase-3/7 dependent
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Figure 3. Polyinosinic-polycytidylic acid (poly(I:C)) induces cell death and pro-apoptotic caspase-3/7 activation. Keratinocytes were treated with medium,
poly(I:C), or flagellin for (b, c) 6 or (a) 24 hours. (a) Arrowheads in phase-contrast images indicate cells at different stages of cell death. Bar¼ 0.05mm.
(b) The number of viable cells and (c) levels of active caspase-3/7 were determined using luminescence assays as described in Materials and Methods.
Relative luminescence units (RLU) are represented as means±standard deviation (SD). *Po0.05; **Po0.01 (compared to medium only).
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(Figure 4c), our data further establish that the pathways
leading to IL36G transcription and activation of cell death
pathways branches after caspase-1 (Figure 6).
DISCUSSION
Preliminary studies indicate that IL-36 has pro-inflammatory
properties (Debets et al., 2001; Towne et al., 2004; Blumberg
et al., 2007; Ramadas et al., 2011); however, the actual
physiological function(s) remain unknown. To explore the
possibility that IL-36 plays a role in immune responses in the
skin, we examined IL-36 expression in keratinocytes chal-
lenged with a panel of TLR ligands. poly(I:C), a double-
stranded RNA analogue, proved to be a very potent activator
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of IL-36g expression and extracellular release. Double-
stranded RNA is a molecular pattern associated with viral
infections, and IL-36g mRNA expression is known to be
upregulated in proliferating keratinocytes during in vivo skin
infections with herpes simplex virus-1 (Kumar et al., 2000).
The direct implication of our observations is that IL-36g
may be involved in regulating innate or adaptive
immune responses aimed at eliminating viral infections in
keratinocytes.
Alarmins are endogenous danger signals released by
pathogen-activated and/or injured cells (Yang et al., 2004;
Oppenheim and Yang, 2005). The functions of alarmins are
to promote both chemotaxis and activation of antigen-
presenting cells (Yang et al., 2004; Oppenheim and Yang,
2005). IL-1a and IL-33, an additional member of the IL-1
family, have previously been characterized as alarmins
largely due to their extracellular release by damaged cells
(Bianchi, 2007; Haraldsen et al., 2009). The observed release
of IL-36g only by dying cells (Figures 2-4) suggests that
extracellular IL-36g may also act as a danger signal to alert
surrounding cells about the cell death. Combined with the
reported involvement of IL-36g in promoting inflammation
(Debets et al., 2001; Towne et al., 2004; Blumberg et al.,
2007; Ramadas et al., 2011) and activation of dendritic and T
cells (Vigne et al., 2011), our observations support the notion
of IL-36g as an alarmin involved in activating the adaptive
immune system in response to pathogen challenges such as
viruses infecting the skin.
Interestingly, both IL36G transcription (Figure 5d) and
caspase-3/7 activation (Figure 5a) are dependent on caspase-1
activation; however, only the secretion of IL-36g is caspase-
3/7 dependent (Figure 4). This demonstrates that the two
pathways branch after caspase-1 (Figure 6). The branching of
the pathways appears to allow the cells to enter a stage of
de novo protein synthesis before committing to self-termina-
tion. This protein synthesis stage may last more than 6 hours
as we observed increased mRNA expression and protein
release between the 6 and 24 hours timepoints (Figures 1 and
2). The subsequent extracellular release of the alarmin IL-36g
from dying cells therefore may not only alert surrounding
cells about the associated tissue damage, but also about the
cause (double-stranded RNA/viral infection) of the cell death.
This may further ensure that a specific immune response
towards viruses is initiated.
Cell death can occur through necrosis or apoptosis. While
the latter does not cause inflammation, the former is highly
inflammatory because the ruptured cell releases cellular
components. Research in recent years have revealed that
there are many other forms of cell death mechanisms, one of
which is pyroptosis (Fink and Cookson, 2005). Pyroptosis is
defined as a form of programmed cell death that is caspase-1
dependent and pro-inflammatory. The latter is mediated
through IL-1b and IL-18. Pyroptosis has so far only been
described in myeloid cells such as macrophages, monocytes,
and dendritic cells (van de Veerdonk et al., 2011). We
observed that poly(I:C) induced keratinocyte cell death and
caspase-3/7 activation (Figure 3). Furthermore, the caspase-3/
7 activation was caspase-1 dependent (Figure 5a). By
definition, the observed keratinocyte cell death should
therefore be described as pyroptosis. This nomenclature is
further supported by the anticipated pro-inflammatory actions
of IL-36 (Debets et al., 2001; Towne et al., 2004; Blumberg
et al., 2007; Ramadas et al., 2011) and our data demonstrat-
ing extracellular release of IL-36g.
Dermatological studies often examine cell death, e.g.,
when studying the effects of UV light on the skin (Weather-
head et al., 2011). UV light has been demonstrated to activate
the inflammasomes and caspase-1 in keratinocytes (Feld-
meyer et al., 2007). Whether the UV-induced apoptosis
reported by Weatherhead et al. (2011) is caspase-1 depen-
dent, and hence could be characterized as pyroptosis, is yet
to be determined. However, distinguishing the different types
of cell death is important, as these have not only distinct
mechanisms of activation and execution, but also have
important differential physiological consequences, e.g.,
inflammation versus no inflammation. Adaptation of the
pyroptosis terminology in the dermatological field is in our
opinion warranted and timely.
Caspase-1 can directly cleave and activate caspase-7, but
not caspase-3 (Lamkanfi et al., 2008). Caspase-3 and -7 have
redundant functions in the execution of apoptosis, i.e. both
must be deleted to prevent apoptosis (Lakhani et al., 2006).
During myeloid pyroptosis caspase-7 but not caspase-3
activation has been observed; however, cell lysis appears to
be independent, at least in some situations, of caspase-7
(Lamkanfi, 2011). Owing to the redundancies between
caspase-3 and -7, the substrate and the inhibitor used in
our studies cannot distinguish caspase-3 and -7 activities.
However, given the previously reported activation of
caspase-7 only in myeloid pyroptosis, our data (Figures 3-5)
likely reflect caspase-7 activity (Figure 6). Interestingly,
although myeloid pyroptotic cell lysis has been reported to
be independent of caspase-7 activation (Lamkanfi, 2011), our
data demonstrate that in keratinocytes the extracellular
release of IL-36g is dependent on caspase-3/7 activity
(Figure 5). This could suggest that the process of pyroptosis
is regulated slightly differently in keratinocytes than in
poly(I:C)
dsRNA IL-36γ
IL-36γ
Cytoplasm
Nucleus
Caspase-1 Caspase-7
Pyroptosis
IL36G
Figure 6. Schematic representation of pathways whereby polyinosinic-
polycytidylic acid (poly(I:C)) and double-stranded RNA may activate IL-36c
expression and secretion. Dashed and dotted line indicates the disintegration
of the cell during pyroptosis. Dashed arrow lines indicate pathways that may
involve several intermediates.
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myeloid cells. The pharmaceutical implication of this may be
that pyroptosis can be specifically inhibited in keratinocytes
without affecting the functions of myeloid cells.
The observed differential accumulation of IL-36g inside
and outside of the cells in response to flagellin and poly(I:C)
(Figure 2) may indicate that IL-36g has both intra- and
extracellular functions, depending on the context in which it
is expressed. Other IL-1 family members such as IL-1a, IL-33,
and IL-37 have been reported to localize in the nucleus.
While the nuclear function of IL-1a is unclear, the presence
of IL-33 or IL-37 in the nucleus appears to suppress pro-
inflammatory gene expression (reviewed in Luheshi et al.,
2009). IL-37 mediates, at least in part, this effect by
interacting with the signaling factor Smad3 (Nold et al.,
2010). Further studies of the intracellular localization of
IL-36g, using e.g., confocal microscopy, could provide
valuable support for, or against, the hypothesis that IL-36g
may have an intracellular function.
Our studies have demonstrated that expression of IL-36g is
highly complex. Strong induction of IL-36g by TLR ligands
suggests that IL-36g plays a role in immune responses against
microorganisms. Furthermore, TLR-specific differential cellu-
lar localization indicates that IL-36g may have distinct
functions dependent on the context in which it is expressed.
Extracellular release of IL-36g during pyroptosis may imply
that IL-36g acts as an alarmin. The specific function of this
danger signal activity may be to inform surround cells about
the nature of the pathogen-causing cell damage and thereby
ensuring engagement of an appropriately specific immune
response. Further studies of the role(s) this exciting cytokine
may play in skin infections and chronic inflammatory
conditions will advance our knowledge of innate and
adaptive immune responses in the skin.
MATERIALS AND METHODS
Cell cultures and cell viability
Pooled human neonatal primary keratinocytes (Invitrogen, Carlsbad,
CA) were maintained in defined keratinocyte serum-free medium
supplemented with 20 mgml1 gentamicin (Invitrogen). Cells were
treated with medium only or a panel of TLR ligands as described
previously (Olaru and Jensen, 2010a). poly(I:C) (Sigma-Aldrich,
St Louis, MO) and recombinant flagellin (Invivogen, San Diego, CA)
were used at 25 and 1mgml1, respectively. All treatments were
performed in duplicate.
Cell viability was evaluated by measuring intracellular levels
of ATP. The medium was removed from treated cells. Cells were
rinsed with phosphate-buffered saline (PBS) and then lysed in
CellTiter-Glo (Promega, Madison, WI) diluted 1/4 in PBS. The
luminescent signal was allowed to stabilize for 10minutes before
measurement.
RNA isolation and real-time reverse transcriptase–PCR
RNA isolation and real-time reverse transcriptase–PCR was per-
formed as described previously (Sanmiguel et al., 2009). IL-1a, IL-
1b, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
complementary DNA-specific primers are described elsewhere
(Olaru and Jensen, 2010b). The following additional gene-specific
primers were used: IL1F6-F2, 50-GACCGTATGTCTCCAGTCAC-30;
IL1F6-R, 50-CTTTAGCACACATCAGGCAG-30; IL1F8-F2C, 50-CAG
CATTAAGCCTGTCACTC-30; IL1F8-R2C, 50-GCACAGAAGAGACA
GAGATC-30; IL1F9-F2, 50-GGGCCGTCTATCAATCAATG-30; IL1F9-
R2, 50-TGATAACAGCAACAGTGACTG-30.
Western blotting
The medium was collected from treated cultures. Cells were rinsed
with PBS and lysed in mammalian protein extraction reagent
(Thermo Fisher Scientific, Rockford, IL) supplemented with 10mM
EDTA and Mammalian Cells Protease Inhibitor Cocktail (Sigma-
Aldrich). Proteins were separated by SDS-PAGE and transferred to
polyvinylidene difluoride membranes. Levels of IL-36b, IL-36g, and
GAPDH were examined using goat anti-IL1F8, goat anti-IL1F9 (R&D
Systems, Minneapolis, MN), and rabbit anti-GAPDH (FL-335) (Santa
Cruz Biotechnology, Santa Cruz, CA) as primary antibodies,
respectively, appropriate horseradish peroxidase secondary anti-
bodies (Santa Cruz Biotechnology), and enhanced chemilumines-
cence reagents (GE Healthcare, Piscataway, NJ).
ELISA
Levels of extracellular IL-36g protein were determined using a direct
ELISA. The medium from treated cells was collected and centrifuged
at 200g for 5minutes. Supernatants were diluted in PBS and coated
overnight onto high-binding ELISA plates. Remaining protein-
binding sites on the ELISA plates were blocked with 1% (wt vol1)
BSA in PBS. IL-36g was detected using sequential incubations with
1mgml1 rat anti-IL-36g (R&D Systems), 250 ngml1 goat anti-rat
IgG-horseradish peroxidase (Santa Cruz), and ABTS (2,2-azino-di-(3-
ethylbenzthiazoline-6-sulfonic acid) chromogen (Invitrogen). The
direct ELISA was confirmed to be specific for IL-36g using
recombinant IL-1a, IL-1b, IL-36a, and IL-36b (PeproTech, Rocky
Hill, NJ and R&D Systems). None of these IL-1 family members were
detected.
Caspase activation and inhibition
Activity of caspase-3/7 was measured using the Caspase-Glo 3/7
Assay (Promega) as described above for the CellTiter-Glo assay.
Caspase-1 and -3/7 were inhibited with caspase-1 inhibitor VI and
caspase-3 inhibitor III (EMD Biosciences, La Jolla, CA). Inhibitors
were solubilized in DMSO (vehicle control) and added to cultures
30minutes before stimulation with medium only or poly(I:C). Final
concentrations were 20–50mM (caspase-1 inhibitor) and 100–250 mM
(caspase-3 inhibitor). Timepoints for examining caspase activation
and inhibition were designed to evaluate activity in the early
induction phases and further optimization performed empirically.
Statistical analyses
Data are shown as arithmetic mean values and standard deviations
from one representative experiment of at least three independent
experiments (n¼ 2 per independent timepoint and treatment within
each individual experiment). Data were analyzed using the Student’s
t-test when appropriate.
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